METTL3 and gastric cancer: METTL3 enhances PARP1 RNA stability, which heightens the activity of the base excision repair pathway and effective repair of oxaliplatin-induced DNA damage in tumor cells, further promoting oxaliplatin resistance in CD133+ gastric cancer stem cells [118].